Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2014

Open Access 01-12-2014 | Research article

Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study

Authors: Sameer D Salem, Riyadh Saif-Ali, Ikram S Ismail, Zaid Al-Hamodi, Sekaran Muniandy

Published in: BMC Endocrine Disorders | Issue 1/2014

Login to get access

Abstract

Background

Several studies have shown the association of solute carrier family 30 (zinc transporter) member 8 (SLC30A8) rs13266634 with type 2 diabetes (T2D). However, the association of alternative variants and haplotypes of SLC30A8 with T2D have not been studied in different populations. The aim of this study is to assess the association of the alternative SLC30A8 variants, rs7002176 and rs1995222 as well as the most common variant, rs13266634 and haplotypes with glutamic acid decarboxylase antibodies (GADA) negative diabetes in Malaysian subjects.

Methods

Single nucleotide polymorphisms (SNPs) of SLC30A8; rs7002176, rs1995222 and rs13266634 were genotyped in 1140 T2D and 973 non-diabetic control subjects. Of these, 33 GADA positive diabetic subjects and 353 metabolic syndrome (MetS) subjects were excluded from subsequent analysis.

Results

The recessive genetic model controlled for age, race, gender and BMI shows that the alternative SLC30A8 variant, rs1995222 is associated with GADA negative diabetes (OR = 1.29, P = 0.02) in Malaysian subjects. The most common variant, rs13266634 is also associated with GADA negative diabetes (OR = 1.45, P = 0.001). This association is more pronounced among Malaysian Indians (OR = 1.93, P = 0.001). Moreover, the CG haplotype and CG-CG diplotype have been equally associated with increased diabetic risk (OR = 1.67, P = 8.6 × 10-5).

Conclusions

SLC30A8 SNPs and haplotypes are associated with GADA negative diabetes in Malaysian subjects, and this association is markedly higher among Malaysian Indian subjects.
Appendix
Available only for authorised users
Literature
1.
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27: 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
2.
Ng MC, Park KS, Oh B, Tam CH, Cho YM, Shin HD, Lam VK, Ma RC, So WY, Cho YS: Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes. 2008, 57: 2226-2233. 10.2337/db07-1583.CrossRefPubMedPubMedCentral
3.
4.
Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, Akahane T, Aoki D, Kamatani N, Hirata K, Nakamura Y: A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet. 2010, 42: 707-710. 10.1038/ng.612.CrossRefPubMed
5.
Qian Y, Lu F, Dong M, Lin Y, Li H, Chen J, Shen C, Jin G, Hu Z, Shen H: Genetic variants of IDE-KIF11-HHEX at 10q23.33 associated with type 2 diabetes risk: a fine-mapping study in Chinese population. PLoS One. 2012, 7: e35060-10.1371/journal.pone.0035060.CrossRefPubMedPubMedCentral
6.
Naik RG, Brooks-Worrell BM, Palmer JP: Latent autoimmune diabetes in adults. J Clin Endocrinol Metab. 2009, 94: 4635-4644. 10.1210/jc.2009-1120.CrossRefPubMed
7.
Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997, 350: 1288-1293. 10.1016/S0140-6736(97)03062-6.CrossRefPubMed
8.
Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G: A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med. 2004, 21: 456-459. 10.1111/j.1464-5491.2004.01177.x.CrossRefPubMed
9.
Roh M-O, Jung C-H, Kim B-Y, Mok J-O, Kim C-H: The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea. Acta Diabetolo. 2010, 47: 1-6.
10.
Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes. 1986, 35: 237-241. 10.2337/diab.35.2.237.CrossRefPubMed
11.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JRB, Elliott KS, Lango H, Rayner NW: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007, 316: 889-894. 10.1126/science.1141634.CrossRefPubMedPubMedCentral
12.
Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G: Latent autoimmune diabetes in adults. Diabetes. 2005, 54: S68-S72. 10.2337/diabetes.54.suppl_2.S68.CrossRefPubMed
13.
Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999, 48: 150-157. 10.2337/diabetes.48.1.150.CrossRefPubMed
14.
Petrie JR, Pearson ER, Sutherland C: Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology. Biochem Pharmacol. 2011, 81: 471-477. 10.1016/j.bcp.2010.11.010.CrossRefPubMed
15.
Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, Been LF, Chia K-S, Dimas AS, Hassanali N: Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011, 43: 984-989. 10.1038/ng.921.CrossRefPubMedPubMedCentral
16.
Cho YS, Chen C-H, Hu C, Long J, Hee Ong RT, Sim X, Takeuchi F, Wu Y, Go MJ, Yamauchi T: Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2012, 44: 67-72.CrossRef
17.
Saxena R, Elbers Clara C, Guo Y, Peter I, Gaunt Tom R, Mega Jessica L, Lanktree Matthew B, Tare A, Castillo Berta A, Li Yun R: Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012, 90: 410-425. 10.1016/j.ajhg.2011.12.022.CrossRefPubMedPubMedCentral
18.
Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007, 445: 881-885. 10.1038/nature05616.CrossRefPubMed
19.
Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007, 316: 1341-1345. 10.1126/science.1142382.CrossRefPubMedPubMedCentral
20.
Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007, 316: 1331-1336.CrossRefPubMed
21.
Consortium TWTCC: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447: 661-678. 10.1038/nature05911.CrossRef
22.
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JRB, Rayner NW, Freathy RM: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007, 316: 1336-1341. 10.1126/science.1142364.CrossRefPubMedPubMedCentral
23.
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007, 39: 770-775. 10.1038/ng2043.CrossRefPubMed
24.
Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S: Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes. 2008, 57: 791-795. 10.2337/db07-0979.CrossRefPubMed
25.
Horikoshi M, Hara K, Ito C, Shojima N, Nagai R, Ueki K, Froguel P, Kadowaki T: Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia. 2007, 50: 2461-2466. 10.1007/s00125-007-0827-5.CrossRefPubMed
26.
Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, Qin W, Hou X, Wang C, Bao Y: PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One. 2009, 4: e7643-10.1371/journal.pone.0007643.CrossRefPubMedPubMedCentral
27.
Xiang J, Li X, Xu M, Hong J, Huang Y, Tan J, Lu X, Dai M, Yu B, Ning G: Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese. J Clin Endocrinol Metab. 2008, 93: 4107-4112. 10.1210/jc.2008-0161.CrossRefPubMed
28.
Xu M, Bi Y, Xu Y, Yu B, Huang Y, Gu L, Wu Y, Zhu X, Li M, Wang T: Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One. 2010, 5: e14022-10.1371/journal.pone.0014022.CrossRefPubMedPubMedCentral
29.
Lin Y, Li P, Cai L, Zhang B, Tang X, Zhang X, Li Y, Xian Y, Yang Y, Wang L: Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet. 2010, 11: 97-10.1186/1471-2350-11-97.CrossRefPubMedPubMedCentral
30.
Lee Y-H, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, Ahn CW, Cha BS, Nam M, Nam CM: Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Humn Genet. 2008, 53: 991-998. 10.1007/s10038-008-0341-8.CrossRef
31.
Tan JT, Ng DPK, Nurbaya S, Ye S, Lim XL, Leong H, Seet LT, Siew WF, Kon W, Wong TY: Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab. 2010, 95: 390-397. 10.1210/jc.2009-0688.CrossRefPubMed
32.
Wu Y, Li H, Loos RJF, Yu Z, Ye X, Chen L, Pan A, Hu FB, Lin X: Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes. 2008, 57: 2834-2842. 10.2337/db08-0047.CrossRefPubMedPubMedCentral
33.
Kifagi C, Makni K, Boudawara M, Mnif F, Hamza N, Abid M, Granier C, Ayadi H: Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 diabetes mellitus in Tunisia. Genet Test Mol Biomarkers. 2011, 15: 399-405. 10.1089/gtmb.2010.0199.CrossRefPubMed
34.
Waters KM, Stram DO, Hassanein MT, Le Marchand L, Wilkens LR, Maskarinec G, Monroe KR, Kolonel LN, Altshuler D, Henderson BE: Consistent association of type 2 diabetes risk variants found in Europeans in diverse racial and ethnic groups. PLoS Genet. 2010, 6: E1001078-10.1371/journal.pgen.1001078.CrossRefPubMedPubMedCentral
35.
Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG: IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings: the Belgian diabetes registry. Diabetologia. 1997, 40: 95-99. 10.1007/s001250050648.CrossRefPubMed
36.
Prentki M, Corkey BE: Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?. Diabetes. 1996, 45: 273-283. 10.2337/diab.45.3.273.CrossRefPubMed
37.
Monk D, Sanches R, Arnaud P, Apostolidou S, Hills FA, Abu-Amero S, Murrell A, Friess H, Reik W, Stanier P: Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet. 2006, 15: 1259-1269. 10.1093/hmg/ddl041.CrossRefPubMed
38.
Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010, 42: 105-116. 10.1038/ng.520.CrossRefPubMedPubMedCentral
39.
Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, Kantartzis K, Schafer SA, Kirchhoff K, Fritsche A, Haring HU: Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One. 2007, 2: e832-10.1371/journal.pone.0000832.CrossRefPubMedPubMedCentral
40.
Kanoni S, Nettleton JA, Hivert M-F, Ye Z, van Rooij FJA, Shungin D, Sonestedt E, Ngwa JS, Wojczynski MK, Lemaitre RN: Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant. Diabetes. 2011, 60: 2407-2416. 10.2337/db11-0176.CrossRefPubMedPubMedCentral
41.
Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L, Grunwald D, Favier A: In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006, 119: 4199-4206. 10.1242/jcs.03164.CrossRefPubMed
42.
Kirchhoff K, Machicao F, Haupt A, Schafer SA, Tschritter O, Staiger H, Stefan N, Haring HU, Fritsche A: Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia. 2008, 51: 597-601. 10.1007/s00125-008-0926-y.CrossRefPubMed
43.
Palmer ND, Goodarzi MO, Langefeld CD, Ziegler J, Norris JM, Haffner SM, Bryer-Ash M, Bergman RN, Wagenknecht LE, Taylor KD: Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the insulin resistance atherosclerosis family study. Diabetes. 2008, 57: 1093-1100. 10.2337/db07-1169.CrossRefPubMed
44.
Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, Koshkin V, Tarasov AI, Carzaniga R, Kronenberger K: Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009, 58: 2070-2083. 10.2337/db09-0551.CrossRefPubMedPubMedCentral
45.
Chausmer AB: Zinc, Insulin and Diabetes. J Am Coll Nutr. 1998, 17: 109-115. 10.1080/07315724.1998.10718735.CrossRefPubMed
46.
Chimienti F: Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev. 2013, 26: 1-11. 10.1017/S0954422412000212.CrossRefPubMed
47.
Salem SD, Saif-Ali R, Ismail IS, Al-Hamodi Z, Poh R, Muniandy S: IGF2BP2 alternative variants associated with glutamic acid decarboxylase antibodies negative diabetes in Malaysian subjects. PLoS ONE. 2012, 7: e45573-10.1371/journal.pone.0045573.CrossRefPubMedPubMedCentral
48.
Rong R, Hanson RL, Ortiz D, Wiedrich C, Kobes S, Knowler WC, Bogardus C, Baier LJ: Association analysis of variation in/Near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes. 2009, 58: 478-488.CrossRefPubMedPubMedCentral
49.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
50.
Chimienti F, Devergnas S, Favier A, Seve M: Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004, 53: 2330-2337. 10.2337/diabetes.53.9.2330.CrossRefPubMed
Metadata
Title
Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study
Authors
Sameer D Salem
Riyadh Saif-Ali
Ikram S Ismail
Zaid Al-Hamodi
Sekaran Muniandy
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2014
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-14-2

Other articles of this Issue 1/2014

BMC Endocrine Disorders 1/2014 Go to the issue

Study protocol

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)

Research article

Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients

Research article

The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies

Case report

Emotionally induced galactorrhoea in a non-lactating female –“Pseudo- Lactation”?

Research article

A pilot study: the development of a culturally tailored Malaysian Diabetes Education Module (MY-DEMO) based on the Health Belief Model

Research article

Association of calcaneal quantitative ultrasound parameters with metabolic syndrome in middle-aged and elderly Chinese: a large population-based cross-sectional study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits